| RS2105200537 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Singleton-Merten syndrome 1 |
| RS2105207249 |
NRXN1
|
Health Risk |
Pathogenic |
Pitt-Hopkins-like syndrome 2, Pitt-Hopkins-like syndrome 2 |
| RS2105222752 |
LRP1B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2105223358 |
LRP1B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2105226927 |
SCN9A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 7 |
| RS2105241166 |
SPR
|
Health Risk |
Pathogenic |
Dopa-responsive dystonia due to sepiapterin reductase deficiency, Dystonic disorder |
| RS2105241347 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS2105241466 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS2105243192 |
SPR
|
Health Risk |
Likely pathogenic |
Dystonic disorder, Dopa-responsive dystonia due to sepiapterin reductase deficiency |
| RS2105243497 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2105244906 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2105244912 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2105245017 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2105247122 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, West syndrome |
| RS2105247156 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2105247197 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS2105247262 |
SCN2A
|
Health Risk |
Pathogenic |
Benign familial infantile epilepsy, Benign familial infantile epilepsy |
| RS2105247288 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2105247310 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS2105247416 |
SCN2A
|
Health Risk |
Pathogenic |
West syndrome, West syndrome |
| RS2105247434 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS2105251415 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2105251438 |
SCN2A
|
Health Risk |
Pathogenic |
See cases, Seizures |
| RS2105251544 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS2105255370 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2105255398 |
SCN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2105255410 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemiplegia/hemiparesis, Inborn genetic diseases |
| RS2105255430 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2105255869 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2105255913 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, West syndrome |
| RS2105259429 |
ORC4
|
Health Risk |
Likely pathogenic |
Meier-Gorlin syndrome 2, Meier-Gorlin syndrome 2 |
| RS2105259560 |
SCN2A
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2105259671 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2105259788 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2105259847 |
SCN2A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, Generalized epilepsy with febrile seizures plus |
| RS2105272332 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2105275776 |
TTC21B
|
Health Risk |
Likely pathogenic |
— |
| RS2105276037 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2105276746 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2105276771 |
SCN2A
|
Health Risk |
Pathogenic |
Benign familial infantile epilepsy, Benign familial infantile epilepsy |
| RS2105276912 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2105277203 |
SCN2A
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2105278194 |
TBR1
|
Health Risk |
Pathogenic |
See cases, Intellectual developmental disorder with autism and speech delay |
| RS2105278359 |
TBR1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2105278575 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2105278913 |
TBR1
|
Health Risk |
Likely pathogenic |
— |
| RS2105279320 |
TBR1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and speech delay, Intellectual developmental disorder with autism and speech delay |
| RS2105280445 |
TBR1
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and speech delay, Intellectual developmental disorder with autism and speech delay |
| RS2105280472 |
TBR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Intellectual developmental disorder with autism and speech delay |
| RS2105282575 |
TBR1
|
Health Risk |
Pathogenic |
— |
| RS2105284299 |
SCN2A
|
Health Risk |
Pathogenic |
— |
| RS2105290053 |
BBS5
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2105291679 |
TTC21B
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS2105291727 |
TTC21B
|
Health Risk |
Pathogenic |
Nephronophthisis, Jeune thoracic dystrophy |
| RS2105291750 |
BBS5
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2105291970 |
TTC21B
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 4, Nephronophthisis 12 |
| RS2105291990 |
TTC21B
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS2105292022 |
TTC21B
|
Health Risk |
Pathogenic |
Nephronophthisis, Jeune thoracic dystrophy |
| RS2105292027 |
TTC21B
|
Health Risk |
Pathogenic |
Nephronophthisis, Jeune thoracic dystrophy |
| RS2105293230 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2105293298 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2105297751 |
BBS5
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2105297825 |
BBS5
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2105300418 |
BBS5
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, BBS5-related disorder |
| RS2105300442 |
BBS5
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 5 |
| RS2105303591 |
BBS5
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 5, Bardet-Biedl syndrome 5 |
| RS2105304338 |
BBS5
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2105306744 |
ORC4
|
Health Risk |
Pathogenic |
— |
| RS2105309832 |
KLHL41
|
Health Risk |
Pathogenic |
Nemaline myopathy 9, Nemaline myopathy 9 |
| RS2105312506 |
KLHL41
|
Health Risk |
Pathogenic |
Nemaline myopathy 9, Nemaline myopathy 9 |
| RS2105312600 |
KLHL41
|
Health Risk |
Pathogenic |
Nemaline myopathy 9, Nemaline myopathy 9 |
| RS2105314804 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS2105317922 |
NRXN1
|
Health Risk |
Pathogenic |
Pitt-Hopkins-like syndrome 2, Pitt-Hopkins-like syndrome 2 |
| RS2105318789 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS2105318837 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2105319097 |
SCN2A
|
Health Risk |
Likely pathogenic |
— |
| RS2105319167 |
SCN2A
|
Health Risk |
Likely pathogenic |
Benign familial infantile epilepsy, Seizures |
| RS2105319172 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2105319200 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2105319230 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2105324384 |
TTC21B
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS2105326044 |
LRP2
|
Health Risk |
Pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS2105327752 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2105329247 |
TTC21B
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis 12, Asphyxiating thoracic dystrophy 4 |
| RS2105329431 |
LRP2
|
Health Risk |
Likely pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS2105336790 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2105336825 |
SCN2A
|
Health Risk |
Likely pathogenic |
Abnormal cerebral morphology, Abnormal cerebral morphology |
| RS2105336842 |
SCN2A
|
Health Risk |
Likely pathogenic |
Seizures, benign familial infantile |
| RS2105336868 |
SCN2A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS2105337298 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2105337522 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2105337639 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS2105338187 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2105343139 |
TTC21B
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS2105343563 |
LRP2
|
Health Risk |
Likely pathogenic |
— |
| RS2105344238 |
NRXN1
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins-like syndrome 2, Pitt-Hopkins-like syndrome 2 |
| RS2105344578 |
TTC21B
|
Health Risk |
Pathogenic |
Nephronophthisis, Asphyxiating thoracic dystrophy 4 |
| RS2105344608 |
TTC21B
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Nephronophthisis |
| RS2105348555 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS2105348670 |
LRP2
|
Health Risk |
Likely pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |